Table 6.
Development history (n) | Screening intervals (months) |
---|---|
Lugol‐stained mucosa surrounding EMR (3) → mF (3) | 9, 13, 48 |
Lugol‐stained mucosa surrounding EMR (3) → MD (3) | 6, 15, 16 |
Lugol‐stained mucosa surrounding EMR (3) → SD (3) | 6, 6, 12 |
Lugol‐stained mucosa surrounding EMR/MD (1) → intramucosal carcinoma (1) | 26 |
Lugol‐stained mucosa surrounding EMR/Bch (1) → SD (1) | 8 |
Lugol‐stained mucosa surrounding EMR/mD (1) → Cis (1) | 18 |
Bch, basal cell hyperplasia; Cis, carcinoma in situ; EMR, endoscopic mucosal resection; mD, mild dysplasia; MD, moderate dysplasia; SD, severe dysplasia.